# Treatment of Age-related Macular Degeneration by Fetal Retinal Pigment Epithelial Cells Transplantation

> **NCT02868424** · EARLY_PHASE1 · UNKNOWN · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 6 (actual)

## Conditions studied

- Age Related Macular Degeneration
- Macular Degeneration
- AMD

## Interventions

- **DRUG:** fRPE cells

## Key facts

- **NCT ID:** NCT02868424
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-02-13
- **Primary completion:** 2018-08
- **Final completion:** 2018-12
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2017-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02868424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02868424, "Treatment of Age-related Macular Degeneration by Fetal Retinal Pigment Epithelial Cells Transplantation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02868424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*